Epidemiological Analysis of COVID-19 Patients detected by Real-Time Reverse Transcription - Polymerase Chain reaction in a Tertiary Care Biosafety Level III Laboratory, Rawalpindi by Anjum, Rabia et al.
128                                                                             Journal of Rawalpindi Medical College (JRMC); 2021; 25(1): 128-133 
Original Article 
 
Epidemiological Analysis of COVID-19 Patients detected by 
Real-Time Reverse Transcription - Polymerase Chain 
reaction in a Tertiary Care Biosafety Level III Laboratory, 
Rawalpindi  
Rabia Anjum1, Nadeem Ikram2, Asma Nafisa3, Naeem Akhtar4  
1 Consultant Pathologist, Department of Pathology, 
Benazir Bhutto Hospital, Rawalpindi.  
2 Associate Professor, Department of Pathology, 
Benazir Bhutto Hospital, Rawalpindi. 
3 Biochemist, Department of Pathology, 
Benazir Bhutto Hospital, Rawalpindi. 
4 Professor, Department of Pathology, 
Benazir Bhutto Hospital, Rawalpindi. 
Author’s Contribution 
1,4 Conception of study  
1  Experimentation/Study conduction  
1,2,3 Analysis/Interpretation/Discussion  
1,3 Manuscript Writing 
2,3 Critical Review 
2,3,4 Facilitation and Material analysis 
Corresponding Author 
Dr. Rabia Anjum, 
Consultant Pathologist, 
Department of Pathology, 




Received:  31/12/2020 
Accepted:  08/03/2021 
 
Cite this Article: Anjum, R., Ikram, N., Nafisa, A., 
Akhtar, N. Epidemiological Analysis of COVID-19 
Patients detected by Real-Time Reverse Transcription - 
Polymerase Chain reaction in a Tertiary Care Biosafety 
Level III Laboratory, Rawalpindi. Journal of Rawalpindi 
Medical College. 30 Mar. 2021; 25(1): 128-133. 
DOI:  https://doi.org/ 10.37939/jrmc.v25i1.1576 
    Conflict of Interest: Nil 






Introduction: Unexpected eruption and global dissemination of Coronavirus disease (COVID-19) has tested the 
healthcare systems of both developed and developing countries. 
Objective: To analyze the spectrum of novel coronavirus infection in a tertiary care setup. 
Materials and Methods: All oropharyngeal and nasopharyngeal samples (n=7057) were collected in a viral 
transport medium (VTM) for qualitative analysis by a real-time reverse transcription-polymerase chain reaction 
(RT-PCR) machine. Positive and negative controls were applied with each batch. Positive cases were stratified into 
mild, moderate, severe, and asymptomatic, according to the guidelines of the National Institute of Health, 
Pakistan. Descriptive statistical tests were applied including percentage, chi-square tests, mean, median, and 
mode. P < 0.05 was counted as statistically significant. 
Results: Average positive test rate was 18.97% (n=1339). The maximum positivity rate (26%) of COVID-19 
infection was observed in June 2020. Most of the cases (60%) belonged to Rawalpindi District, were male (n=844, 
63.03%), and belonged to age group (20-40 years) and mean of 36 and age range from 2-85 years. Forty-nine 
percent of COVID-19 infected patients were asymptomatic and only 9.8% progressed to severe disease.  Overall, 
the mortality rate was 159(11.87%) in RT-PCR confirmed cases. 
Conclusion: Average positive test rate was 18.97%. The majority of the participants belonged to the young age 
group (20-40 yrs.) with a range from 2 to 85 years. Forty-nine percent positive COVID-19 infected patients were 
asymptomatic while 9.8% had severe disease. 
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Introduction 
 
Unexpected eruption and global dissemination of 
Coronavirus disease (COVID-19) have challenged the 
nations. Pakistan is presently suffering through the 
second wave of infection. The causative agent Severe 
Acute Respiratory Syndrome Coronavirus (SARS-
CoV-2) belongs to the family Coronoviridae, having 
79% homology with SARS-CoV-2.1-4 
The high infectivity has prompted rapid respiratory 
droplet transmission of SARS-CoV-2 generated by 
speaking, coughing, or sneezing and direct physical 
contact, from human to human.2,3,4,5,6 Generally, males 
with SARS-CoV-2 are at higher risk for poor prognosis 
and mortality, independent of the age variable.4,7,8 
Mostly SARS-CoV-2 infected patients remain 
asymptomatic initial stages of the disease with only 
chills and respiratory symptoms.4,5,9 However, 
moderate to very severe complications can be 
witnessed in many cases. These offered characteristic 
clinical symptoms for diagnosis.9 In addition to 
virological findings, changes in other laboratory 
parameters such as an increase in neutrophils count 
with a high neutrophil to lymphocytes ratios (NLR), 
elevated D-dimer levels, and increase in C-reactive 
protein, and other inflammatory markers have also 
been seen in severely infected patients.10,11 Early 
identification, patient isolation, and timely treatment is 
a fundamental strategy to restrict transmission from 
human-to-human thus reducing the chances of 
secondary infections among close contacts and 
healthcare workers.1,2,8,12,13  
The PCR test on upper respiratory tract samples is 
considered a prime tool of diagnosis. However, cases 
with negative results, but showing positive findings on 
HRCT (ground glass opaqueness in peripheral lung 
fields) are reported. As RT-PCR is considered the most 
definite laboratory identification method in the 
pandemic, it provides an adequate and satisfactory 
way to confirm nCOVID-19 infection within 6-8 hours 
in case of COVID-19 infection also.3,12,14 
After confirmation of the first two patients with 
COVID-19 on 25th Feb 2020, a hospital-based 
surveillance system for SARS-CoV-2 infection was 
initiated across Pakistan.15,16 Various hospitals assessed 
symptomatic patients and close contacts, collected, 
and referred specimen to designated PCR 
laboratories.15,17 The diagnostic capability has been 
judiciously supported by involving both public and 
private sector laboratories in Pakistan. However, the 
already scanty resources of Pakistan's health care 
system have been further tightened.4,16 
Materials and Methods 
 
Objectives: 
• To compile and analyze the demographic 
profile, clinical presentation, contact history of all 
COVID-19 patients detected by RT-PCR.  
• Demographic information for reported 
COVID-19 cases may offer data on populations that 
are at increased risk of COVID-19 infection. 
•  To provide awareness and outreach to high-
risk populations and identify any discrepancies that 
merit further search or focus.  
• The data will help in a better understanding of 
this extensive infection to work in a coordinated way 
after proper managerial planning and adopt timely 
effective preventive measures to curtail further spread 
of disease.2,12 
Study design: This cross-sectional descriptive 
observational study was carried out in Benazir Bhutto 
Hospital Biosafety level III COVID-19 infection PCR 
testing laboratory which is the only laboratory with a 
Biosafety level III facility in the public sector of 
Rawalpindi district receiving respiratory samples for 
PCR testing from the whole district including its 
residential areas, offices, quarantine centers as well as 
primary and tertiary care hospitals either directly or 
through district health authorities 
Sampling technique: We analyzed all samples received 
from the Rawalpindi District for SARS-CoV-2 RT-PCR 
testing by using a non-probability convenience 
sampling technique from 2nd May 2020 to 31st July 
2020.  
Inclusion criteria: All records of suspects/patients 
investigated for SARS-CoV-2 by PCR testing in BBH 
BSL III LAB. COVID-19 positive population of 
Rawalpindi District whose samples were received for 
PCR testing of Covid-19 infection on clinical and or 
epidemiological suspicion by medical teams of the 
respective designated hospitals was included.  
Exclusion criteria: Data of all patients not tested in 
BBH BSL III laboratory. 
Data Collection: The data was collected at the time of 
sample collection, uploaded on Primary and 
secondary health information systems on daily basis, 
and updated by the district health authority and 
Benazir Bhutto Hospital laboratory personnel as per 
routine. A total number of 7057 tests were conducted 
on patients/suspects based on a high index of 
suspicion for COVID-19 infection due to characteristic 
respiratory tracts infection symptoms such as fever, 
cough, and breathlessness, or history of close contact 
with SARS-CoV-2 patients in three months  
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from 2nd May 2020 to 31st July 2020 in Rawalpindi 
district biosafety level 3 laboratory at Benazir Bhutto 
Hospital. The epidemiological characteristics of the 
patients were recorded. Results of real-time PCR for 
SARS-CoV-2 on respiratory specimens (pharyngeal 
and/or nasal swabs) were collected from laboratory 
records. All data was saved by laboratory personnel 
on HISDU COVID-19 Dashboard and Microsoft excel 
sheet. The clinical classification of 
confirmed/suspected cases into asymptomatic, mild, 
moderate, severe, and critical was done according to 
the hospital protocol and National Institute of Health, 
Pakistan guidelines for COVID 19 infection.3,15,16 
RNA extraction: RNA was extracted manually using 
Geneaid extraction kits following the manufacturer's 
instructions. COVID-19 was qualitatively analyzed 
using CFX 96 real-time PCR machine and (nCoV-19) 
Nucleic Acid Diagnostic Kit (BGI, Inc. China) 
according to the manufacturer’s instructions. The test 
was performed on SARS-CoV-2 Nucleic acid detection 
kit (PCR-Fluorescent Probe method) (CE-IVD), 
intended for the qualitative dual-target open reading 
frame 1ab, nucleocapsid protein gene fragments 
(ORF1ab/N Gene) detection of SARS-CoV-2, the virus 
that causes COVID-19 disease, in nasopharyngeal and 
oropharyngeal swab samples from patients (who meet 
COVID-19 clinical and/or epidemiological criteria for 
testing) with internal and external positive controls. 
Conditions for amplification were as recommended by 
the manufacturer. A medium load required retesting 
for confirmation. Positive and negative controls were 
applied with each batch of tests for quality control.15,16 
Statistical analysis: Data was analyzed on a Microsoft 
excel sheet for intergroup differences. Descriptive 
statistical tests were applied including percentage, chi-
square tests, mean, median, and mode. P < 0.05 was 




Total 7057 PCR tests were performed in three months' 
duration in BSL III PCR Lab BBH. Laboratory data of 
1339 COVID-19 positive patients were included in the 
final analysis. The majority of the subjects presented 
for the COVID-19 test were from Quarantine areas and 
home isolation (n=3833, 54.3%) followed by RMU and 
Allied Hospitals. However, the positivity rate was 
found to be highest (29%, n=845/2916) in patients 
referred to RMU and Allied Hospitals compared to 
12.36% and 6.50% from quarantine area/home 
isolation and secondary care hospitals, respectively. 
Additionally, out of total RT-PCR SARS-CoV-2 
confirmed cases larger proportion was contributed by 
RMU and Allied Hospitals (63.1%, n=845/1339) (Table 
1). The average positivity rate was 18.97% (n=1339) 
with a maximum (26% n=915) observed in June (Table 
2 and Figure 1). The majority of the subjects (49%) 
were asymptomatic, while 9.8% had severe disease 
(Table 3). Though males (63.03%) constituted the 
predominant gender the difference in infectivity rate 
among both the sexes was not significant (p=0.074) 
(Table 4). The overall age of patients was in the range 
of 2 and 85 years with a median age of 41.5 years. 
Although a maximum number of subjects tested for 
COVID-19 belonged to the age group 20-40 years 
(49.70%, n=3508/7057) with a mean age of 36, the 
highest positivity rate was observed in the age group 
40-60 years. (23.34%, n=396/1704) (Table 5). The 
statistical difference of the age variable was non-
significant. Out of total COVID-19 positive patients 
tested in BBH BSL III laboratory, 159 deaths were 
recorded (11.87%) during the study period. Death rate 
was higher in males (n=108, 67.92%) as compared to 
females (n=51, 32.07%). 
 
 












RMU and Allied Hospitals 2916 845 2071 29.00 63.1  
>0.05 
 
Quarantine areas and home isolation 3833 474 3359 12.36 35.4 
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May 1294 276 21.00 
June 3563 915 26.00 
July 2200 148 6.70 
 
Figure 1: Monthly Distribution of PCR SARS-CoV-2 
Samples 
 
Table 3: Clinical Presentation of COVID-19 Cases 
Presenting Symptoms   Frequency n (%) 
Asymptomatic 656 (49%) 
Mild 362 (27%) 
Moderate 189 (14.1%) 
 
 



















Total 7057 1339 5718 
 
Table 5: Age-wise Distribution of COVID-19 Cases 
Age (years) Total Tests Positive (n) Negative (n)  Positivty Rate (%) P-Value 
0-20 1156 209  947 18.08  
 
4.35 
20-40 3508 582  2926 16.59 
40-60 1704 396 1308 23.24 
61 & Above 689 152 537 22.06 




On 26th February 2020, the first laboratory-confirmed 
case of COVID-19 disease was recorded in Pakistan. 
Risk awareness communication, early detection of 
positive COVID-19 cases, proper tracing of contacts, 
social distancing, creation of quarantine centers, 
isolation wards, increase in lab diagnostic capability, 
and donations for the safety of people were the major 
interventions carried out by the country. The regional 
strains found on the ORF1-b gene sequence were 
categorized into clade A3. It showed complete 
homology with the strains identified in adjacent 
countries like China and India.7,18-20 
Depending on the available data it is evident that the 
peak was seen in June 2020 in the Rawalpindi region. 
Overall positivity rate in the Rawalpindi district 
remained 19% during the study period which is almost 
as high as in other districts like Faisalabad (17.9%) and 
Karachi. National Institute of Health, Islamabad, 
documented an 8.27% positivity rate but a study in 
Wuhan showed a very high rate of 38.4% based on 
PCR testing. Evidence has shown the stability of this 
virus and verified its existence in the air for almost 8 
hours and 16–24 hours on various inanimate surfaces 
like wood and plastics. The respiratory droplets of the 
virus in the air may spread up to 1 to 2 metres and can 
easily be transmitted to other individuals by 
inhalation.8,17,22 So, timely control measures are very 
important to curtail the spread of SARS-CoV-2 
infection in our population.5,8,21 Sixty-three percent of 
our patients presented in tertiary care hospitals and 
the least showed up in primary and secondary care 
areas showing the increased patient burden on tertiary 
care setups. Quarantine and field hospital centers 
catered 35% of laboratory-confirmed COVID-19 cases. 
Almost half (49%) of the SARS-CoV-2 positive cases 
were asymptomatic at the time of testing and the 
remaining study population presented with a different 
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range of symptoms. Similar results were documented 
by Badar et al showing 68% asymptomatic cases 
whereas only 32% were symptomatic.15 Contrary to 
this Tahir et al in Karachi recorded 91% symptomatic 
lab-confirmed patients presenting with at least one 
symptom with higher fatality over the age of 80.3 This 
can be due to the presentation of only symptomatic 
patients in the catchment isolation hospitals. Similarly, 
in a study in Hubei, only 12.3% of patients developed 
symptoms, and most were asymptomatic (71.2%) 
having only a contact history with COVID-19 disease 
positive cases. The major proportion of the 
symptomatic patients in the mentioned study 
presented with mild symptoms only as in our study 
(29%) like fever (84.9%) and cough (21.9%).26 COVID-
19 infection is mainly associated with respiratory 
complications so, routine radiological assessments and 
high-resolution Computerized Tomography scan tests 
are also crucial for diagnosis.10,17 
The male gender was affected almost twice as much 
(63.03%) as females (36.96%). Similar results were 
documented in local studies carried out in Karachi and 
Faisalabad showing 64.6% and 78.3% males in total 
SARS-CoV-2 positive patients, respectively.3,17 This 
proportion is endorsed by another study carried out in 
Wuhan where 56% population affected were males.1,21 
A similar study of approximately 150 COVID-19 cases 
from Wuhan documented 50% male.13 Generally, more 
males are affected and tested but statistically, the 
positivity rate was almost the same in both genders as 
verified by P-value as documented in all study setups 
mentioned here. 
The majority of the participants belonged to the age 
group 20-40 years (43.46%) followed by 40-60 years 
(29.6%) with a mean and median age of 36 and 41.5 
years, respectively. The age of COVID-19 patients was 
in the range of 2 and 85 years. One of the factors 
affecting it can be the younger median age of the 
Pakistani population (21.5 years) as documented in 
2015. The age-wise difference in the positivity rate was 
also not statistically significant (P-value > 0.05) 
showing that age is not the main defining factor in 
COVID-19 disease. Similarly, age groups 37-47 (45%) 
and 21-40 (43%) years were the most infected with this 
pandemic virus in Faisalabad and Karachi study 
population, respectively. The majority of the patients 
belonged to the same age group 30–39 years (n = 1097) 
in a study in Wuhan.1,13 Similarly, no significant 
statistical difference (p-value > 0.05) was found based 
on the age among COVID-19 infected patients in the 
studies carried out in Faisalabad, Karachi, and 
Wuhan.1,3,17 
Male gender has emerged as a substantial risk factor of 
mortality in the COVID-19 pandemic.23,24,25 According 
to Jin et al., males are more prone to progress to severe 
disease. In their retrospective study, even though, men 
and women had a similar predisposition, the death 
rate was quite higher in males and causing almost 2.5 
times higher mortality as compared to the female 
population.3,4 Similar results were documented in our 
study with 67.9% versus 32.07% female to male death 
rate23 among the patients tested for COVID-19 
infection.  
There is an ongoing increase in diagnostic services in 
the public sector on a massive scale. Enhanced 
surveillance and improvement in infrastructure for the 





1. A high prevalence rate (18.9%) of COVID-19 
infection was observed. The majority of the 
participants belonged to the young age group 
(20-40 yrs.). The mild disease was found in 
59%, while 9.8% had severe disease. The death 
rate was almost twice in males as compared to 
the female sex. 
2. Pakistan is struggling hard to control the 
pandemic by adopting various precautionary 
measures such as isolation and quarantine 
facilities, lockdown, and community 
awareness programs, to face the continuous 
rise in the COVID-19 cases. 
3. Scaling-up of public health measures and 
upfront efforts to strengthen diagnostic and 
treatment services, most importantly in public 
sector health facilities, reflects the resilience of 
our healthcare system. 
4. Prevailing uncertainty, about COVID-19 
disease, behavior, and the possible emergence 




A few limitations are there in our study. Patients 
included in this study belong to only one district 
(Rawalpindi) of Pakistan. A review on a larger scale 
from various areas of the country may further reflect 
accurate statistics regarding the patient’s 
demographics. Moreover, the study duration was only 
three months. Comprehensive scrutiny of the 
laboratory parameters, clinical presentations, 
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complications, and predictive markers is endorsed to 
acquire an improved vision of the infection and its 
accompanying matters, which can support the 
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